A Phase 3 interventional study of pyeloplasty in Ureteropelvic Junction Obstruction, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-09.
Sponsored by Cairo University · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
an intervention study on adult patients with uretero-pelvic junction obstruction (UPJO) due to crossing vessels would be managed either through classic dismembered pyeloplasty or vascular hitch.
in recent studies, some patients with crossing vessels UPJO could be managed by vascular displacement of these vessels, what is named as vascular hitch or vasculopexy in a way to avoid classic dismembered technique. this newer technique is supposed to provide comparable results to the classic technique but with lesser operative time and shorter hospital stay. in the era of minimally invasive procedures, robotic assisted or laparoscopic vascular hitch could provide many advantages over the classic open technique.
26 studies on the registry are indexed under Multicystic renal dysplasia, bilateral; 9 are open to participants now.
This study's planned enrollment of 17 is below the median of 40 across 20 interventional studies indexed under Multicystic renal dysplasia, bilateral.
Browse Multicystic renal dysplasia, bilateral studies →Cairo University is the lead sponsor of 4,951 studies on the registry; 1,463 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
displacement of the lower polar crossing vessels causing the UPJO
Procedure: pyeloplasty
classic Anderson-Hynes procedure
Procedure: pyeloplasty
repair of the uPJO
comparing the two techniques regarding the success rate
both techniques are supposed to have similar results
Time frame: 2 years
Plan to share: Undecided — the researchers would determine whether they would share or not during the study
No publications or documents are linked to this record.
Started Jun 2023 (actual). Primary completion is estimated for Jun 2025, 24 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Multicystic renal dysplasia, bilateral →